Periodic Reporting for period 1 - CATKERB (Total Syntheses of Catharanthine and Keramaphidin B by an Iridium-Catalyzed Reductive Cyclization Cascade)
Reporting period: 2020-08-03 to 2022-08-02
Objectives: Therefore, the overall objectives of this project can be summarized as follows: a) To develop general reductive transition metal-catalyzed di- and trifluoromethylations of tertiary amides and lactams to furnish valuable fluorinated cyclic and acyclic tertiary amines and b) to systematically apply these methods to the late-stage functionalization of various drugs and natural products to point out the great value of this reaction for medicinal chemistry and society (Scheme 1B).
Conclusion: A broadly applicable and efficient method for the synthesis of acyclic and cyclic α-difluoroalkylated tertiary amines with good overall yields has been developed. The mild iridium-catalyzed reductive difluoroalkylation shows excellent functional group tolerance with respect to both coupling partners; amides/lactams and organozinc reagents, which is among other things highlighted by the late-stage derivatization of four drug molecules. Furthermore, the synthetic utility of this method was demonstrated by a satisfying performance on gram scale and several useful downstream functionalizations (Scheme 2).
Exploitation and dissemination: The works of this project have been presented and discussed in several internal Dixon group seminars as well as in poster sessions of the university’s chemistry department. So far, the fellowship has resulted in the publication of one paper: P. Biallas, K. Yamazaki, D. J. Dixon Org. Lett. 2022, 24, 10, 2002–2007. At the moment, there is a manuscript in preparation on the results of the CATKERB project. It will be submitted in a few weeks to the leading journal JACS. Also, a new reductive trifluoromethylation method developed during this project and their applications will be patented in the near future.